Medivation Gets Hostile After Sanofi's "Misleading" Maneuvers

The biotech continues to reject offers from the French pharma and lays out the problems it has with the offer to shareholders. Meanwhile, Sanofi has taken its bid hostile and pushes to replace the biotech's board.

Medivation Inc. continues to thwart Sanofi's attempts to take over the oncology company, urging shareholders to reject Sanofi's "maneuver" to replace its board of directors.

Medivation sent a letter to shareholders on June 23 laying out the false claims that its potential acquirer has made....

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip